Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Prana Biotechnology Ltd (ATHE : NSDQ)

• Company Description    Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses. Prana's technology has emerged from its researchers at prominent international institutions such as Massachusetts General Hospital at Harvard Medical School and the University of Melbourne. Number of Employees: 11

• Price / Volume Information    Yesterday's Closing Price: $0.66 Daily Weekly Monthly 20 Day Moving Average: 140,088 shares Shares Outstanding: 22.60 (millions) Market Capitalization: $14.98 (millions) Beta: 1.32 52 Week High: $2.75 52 Week Low: $0.58 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.05% -7.27% 12 Week -22.00% -15.70% Year To Date -7.97% 9.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL LEVEL 3 460 BOURKE STREET - MELBOURNE,C3 VIC 3000 AUS ph: 61-3-9349-4906 fax: 61-3-9348-0377 we-aualterity@we-worldwide.com http://alteritytherapeutics.com

• General Corporate Information    Officers David A. Stamler - Chief Executive Officer Geoffrey P. Kempler - Chairman Kathryn J.E. Andrews - Chief Financial Officer Lawrence B. Gozlan - Director Peter A. Marks - Director Peer Information Prana Biotechnology Ltd (CORR.) Prana Biotechnology Ltd (RSPI) Prana Biotechnology Ltd (CGXP) Prana Biotechnology Ltd (BGEN) Prana Biotechnology Ltd (GTBP) Prana Biotechnology Ltd (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 02155X106 SIC: 2834 Fiscal Year Fiscal Year End: June Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 22.60 Most Recent Split Date: 3.00 (0.17:1) Beta: 1.32 Market Capitalization: $14.98 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.50 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - - 12/31/21 - - 09/30/21 - - Current Ratio 03/31/22 - - 12/31/21 - 11.92 09/30/21 - - Quick Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - - Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - - 12/31/21 - 1.33 09/30/21 - - Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©